Trials / Terminated
TerminatedNCT01644136
Microspheres in Preventing Lymphatic Fluid Collection After Surgery in Patients With Prostate Cancer
A Pilot Clinical Trial for the Prevention of Postoperative Lymphoceles Using Absorbable Micorporous Polysaccharide Hemosphere Particles During Robotic Assisted Prostatectomy With Lymph Node Dissection
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 99 (actual)
- Sponsor
- Ohio State University Comprehensive Cancer Center · Academic / Other
- Sex
- Male
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This study is being performed to investigate if the application of Arista absorbable hemostat (AH)®, a product approved to stop surgical bleeding, can prevent lymphoceles. Lymphoceles are collections of lymphatic fluid which can occur after a lymph node dissection for cancer. These fluid collections can become symptomatic in some patients. Arista would be applied to one side of the pelvis after a pelvic lymph node dissection, to see if this decreases the number of postoperative lymph fluid collections seen on a computed tomography (CT) scan after surgery
Detailed description
PRIMARY OBJECTIVES: I. To determine whether, if applied to the lymph node basins after pelvic lymph node dissection, Arista could potentially reduce the formation of lymphoceles and consequently the need for secondary interventions. OUTLINE: Patients undergo standard robotic assisted laparoscopic prostatectomy with pelvic lymph node dissection. After lymph node dissection, patients undergo microsphere-mediated lymphocele prevention to the lymph node basin on one side of the pelvis. After completion of study treatment, patients are followed up at 3 months.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | robot-assisted laparoscopic surgery | Undergo standard robotic assisted laparoscopic prostatectomy |
| PROCEDURE | regional lymph node dissection | Undergo pelvic lymph node dissection |
| DEVICE | microsphere-mediated lymphocele prevention | Undergo microsphere-mediated lymphocele prevention |
Timeline
- Start date
- 2011-07-14
- Primary completion
- 2014-05-06
- Completion
- 2014-05-06
- First posted
- 2012-07-18
- Last updated
- 2018-06-28
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01644136. Inclusion in this directory is not an endorsement.